The Dose-Effect Relationship of Wenxin Granules in the Treatment of Atrial Premature Beats
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
A Randomized, double-blind, placebo-controlled, four dose groups, post-marketing clinical
trial, to evaluate the efficacy and safety of Wenxin granules in treating atrial premature
beats by different doses,to provide a scientific basis for rational clinical use of drug.